| Name | Title | Contact Details |
|---|
Elephant Pharmacy is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Rush-Copley Medical Center, Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Aurora, IL. To find more information about Rush-Copley Medical Center, Inc, please visit www.rushcopley.com
SEEPOINT TECHNOLOGY is a Redondo Beach, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The MetroHealth System is an essential health system committed to providing health care to everyone in Cuyahoga County, Ohio, and improving the health of the community overall. Its 6,700 employees deliver care to everyone at its main campus, just west of downtown Cleveland, and at more than 20 other MetroHealth locations. It also provides health care at more than 20 additional sites in Cuyahoga County through community partnerships such as the School Health Program. MetroHealth is home to Cuyahoga County`s only verified Level I Adult Trauma Center and Level II Pediatric Trauma Center, and it is the only adult and pediatric burn center in the state of Ohio verified by the American Burn Association and the Committee on Trauma of the American College of Surgeons. In the past year, MetroHealth provided more than one million patient visits in its hospital and health centers. MetroHealth also is an academic medical center committed to teaching and research; each of its active physicians holds a faculty appointment at Case Western Reserve University School of Medicine. MetroHealth has earned Magnet status, which places it in the top 6 percent of all hospitals nationwide for nursing excellence. The MetroHealth System makes every effort to ensure that in every phase of the recruitment and selection process, equal employment is provided to all individuals, regardless of race, color, gender, sex, age, creed, disability, national origin or citizenship, veteran`s status, sexual orientation, gender identity, religious affiliation, socio-economic standing, pregnancy and/or genetic information, and any other protected characteristic. MetroHealth`s mission is, “Leading the way to a healthier you and a healthier community through service, teaching, discovery and teamwork.”
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.